Noel Donnelly

Noel serves as the Chief Financial Officer at PepGen. Prior to joining PepGen, Mr. Donnelly worked as the CFO at EIP Pharma Inc., a small private biotech in the neurodegenerative disease space. Before joining EIP Pharma, he spent 15 years at Shire PLC in various leadership within both research & development (R&D) and finance functions. More recently, Mr. Donnelly was Vice President, R&D Business Operations where he established and led key strategic processes and teams including R&D strategy, portfolio prioritization, due diligence and integrations. Mr. Donnelly previously held positions of increasing responsibility within the Shire finance organization, culminating as the Head of R&D Finance. Mr. Donnelly received his MBA with a Concentration in Finance from Babson College and his Bachelor of Science in Nuclear Engineering with a Minor in Economics from the University of Massachusetts-Lowell.